文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

低剂量氯胺酮静脉推注与短时间输注治疗急诊疼痛的前瞻性随机双模拟试验

A prospective randomized, double-dummy trial comparing IV push low dose ketamine to short infusion of low dose ketamine for treatment of pain in the ED.
PubMed 文献 · Am J Emerg Med · 2017-03-03
一句话结论急诊急性疼痛用低剂量氯胺酮0.3mg/kg时,短时间输注较静脉推注不现实感和镇静更少,镇痛效果无差异。

该前瞻性随机双模拟试验纳入48例18–65岁、急诊就诊的急性腹部、侧腹部或肌肉骨骼疼痛且初始疼痛评分≥5的患者,随机接受氯胺酮0.3mg/kg静脉推注或短时间输注。静脉推注组不现实感总体发生率92% vs 短时间输注组54%(差值37.5%;P=0.008;95%CI 9.3–59.5%),5分钟时不现实感中位严重度3.0 vs 0.0(P=0.001),5分钟时RASS中位镇静评分-2.0 vs 0.0(P=0.01)。两组从基线到15分钟的平均疼痛评分下降相似:静脉推注组5.2±3.53(95%CI 3.7–6.7),短时间输注组5.75±3.48(95%CI 4.3–7.2)。生命体征变化和补救药物需求无统计学显著差异。

要点

  • 急诊急性疼痛(腹部、侧腹部或肌肉骨骼)初始评分≥5的18–65岁患者,氯胺酮0.3mg/kg短时间输注较静脉推注不现实感发生率更低(92% vs 54%,P=0.008)。
  • 5分钟时不现实感中位严重度静脉推注组3.0 vs 短时间输注组0.0(P=0.001),短时间输注组更轻。
  • 5分钟时RASS中位镇静评分静脉推注组-2.0 vs 短时间输注组0.0(P=0.01),短时间输注组镇静更浅。
  • 两组从基线到15分钟疼痛评分下降相似:静脉推注组5.2±3.53 vs 短时间输注组5.75±3.48,镇痛效果无差异。
  • 两组生命体征变化和补救药物需求无统计学显著差异。

适用人群与场景

  • 18–65岁因急性腹部、侧腹部或肌肉骨骼疼痛就诊于急诊,初始疼痛评分≥5的患者。

处置流程与药物剂量

  • 氯胺酮0.3mg/kg,采用静脉推注或短时间输注两种给药方式之一,并配合安慰剂双模拟。

研究设计与关键结果

  • 研究类型为前瞻性随机双模拟试验,样本量48例,人群为急诊急性腹部、侧腹部或肌肉骨骼疼痛且初始疼痛评分≥5的18–65岁患者,干预为氯胺酮0.3mg/kg静脉推注 vs 短时间输注。
  • 主要终点不现实感总体发生率:静脉推注组92% vs 短时间输注组54%(差值37.5%;P=0.008;95%CI 9.3–59.5%)。
  • 5分钟时不现实感中位严重度:静脉推注组3.0 vs 短时间输注组0.0(P=0.001)。
  • 5分钟时RASS中位镇静评分:静脉推注组-2.0 vs 短时间输注组0.0(P=0.01)。
  • 从基线到15分钟平均疼痛评分下降:静脉推注组5.2±3.53(95%CI 3.7–6.7) vs 短时间输注组5.75±3.48(95%CI 4.3–7.2)。
  • 生命体征变化和补救药物需求两组无统计学显著差异。

证据类型、等级与局限

  • 证据类型为前瞻性随机双模拟试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于急诊急性腹部、侧腹部或肌肉骨骼疼痛且初始疼痛评分≥5的18–65岁患者,采用氯胺酮0.3mg/kg短时间输注较静脉推注可显著降低不现实感发生率和镇静程度,且镇痛效果无差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: Compare adverse effects and analgesic efficacy of low-dose ketamine for acute pain in the ED administered either by single intravenous push (IVP) or short infusion (SI).

METHODS: Patients 18-65, presenting to ED with acute abdominal, flank, or musculoskeletal pain with initial pain score≥5, were randomized to ketamine 0.3mg/kg by either IVP or SI with placebo double-dummy. Adverse effects were evaluated by Side Effects Rating Scale for Dissociative Anesthetics (SERSDA) and Richmond Agitation-Sedation Scale (RASS) at 5, 15, 30, 60, 90, and 120min post-administration; analgesic efficacy was evaluated by Numerical Rating Scale (NRS).

RESULTS: 48 patients enrolled in the study. IVP group had higher overall rates of feeling of unreality on SERSDA scale: 92% versus 54% (difference 37.5%; p=0.008; 95% CI 9.3-59.5%). At 5min median severity of feeling of unreality was 3.0 for IVP versus 0.0 for SI (p=0.001). IVP also showed greater rates of sedation on RASS scale at 5min: median RASS -2.0 versus 0.0 (p=0.01). Decrease in mean pain scores from baseline to 15min was similar across groups: 5.2±3.53 (95% CI 3.7-6.7) for IVP; 5.75±3.48 (95% CI 4.3-7.2) for SI. There were no statistically significant differences with respect to changes in vital signs and need for rescue medication.

CONCLUSION: Low-dose ketamine given as a short infusion is associated with significantly lower rates of feeling of unreality and sedation with no difference in analgesic efficacy in comparison to intravenous push.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Motov S, Mai M, Pushkar I, et al. A prospective randomized, double-dummy trial comparing IV push low dose ketamine to short infusion of low dose ketamine for treatment of pain in the ED. Am J Emerg Med. 2017. PMID: 28283340. doi:10.1016/j.ajem.2017.03.004

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。